Allez Health

Allez Health Inc., formerly known as Zense-Life Inc., is a pioneering biosensor company focused on developing continuous glucose monitoring (CGM) technology. The company's core offering is a CGM biosensor platform that leverages novel sensor technology aimed at disrupting the cost barrier associated with existing CGM solutions while enhancing performance and user experience.

Allez Health's innovative CGM sensor is designed to provide reliable and accurate glucose monitoring at an affordable price point, addressing the need for accessible and cost-effective diabetes management solutions. The company's sensor technology has undergone extensive development and testing, with seven issued patents and over 40 pending patent applications to date.

Allez Health has made significant strides in its sensor development journey, conducting over 80 clinical studies involving more than 1,500 users. Additionally, the company has completed a pivotal study with 120 insulin users, marking a critical milestone in its journey toward commercialization.

While the Allez Health sensor is still an investigational device pending regulatory approvals, the company is actively working toward obtaining the necessary clearances and approvals to bring its innovative CGM solution to multiple global markets.

Key customers and partnerships

In May 2024, Allez Health secured a strategic investment of USD 60 million in a Series A+ financing round led by the Korean in-vitro diagnostics company, Osang healthcare Co., Ltd., along with participation from existing investors. This funding will support Allez Health's operations, clinical development, regulatory approval filings, and scaling of manufacturing operations.

The collaboration with Osang healthcare, a world-class manufacturer with global reach, is expected to facilitate meaningful access to Allez Health's CGM technology for millions of people with diabetes and the broader wellness market. Osang healthcare's strategic investment and manufacturing capabilities will play a crucial role in Allez Health's commercialization efforts.